AVAI

Atlas Venture Associates IX Portfolio holdings

AUM $11.8M
This Quarter Return
+6.42%
1 Year Return
-58.35%
3 Year Return
-89.8%
5 Year Return
-87.69%
10 Year Return
AUM
$57.4M
AUM Growth
+$57.4M
Cap. Flow
-$4.71M
Cap. Flow %
-8.21%
Top 10 Hldgs %
100%
Holding
7
New
Increased
Reduced
Closed
1

Top Buys

No buys this quarter

Sector Composition

1 Healthcare 95.73%
2 Communication Services 4.27%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
NTLA icon
1
Intellia Therapeutics
NTLA
$1.22B
$23.7M 41.29% 1,615,321
SPRO icon
2
Spero Therapeutics
SPRO
$116M
$13.2M 23.08% 1,376,968
SURF
3
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$8.73M 15.22% 4,645,453
SYBX icon
4
Synlogic
SYBX
$17M
$6.84M 11.92% 2,651,963
SNAP icon
5
Snap
SNAP
$12.1B
$2.45M 4.27% 150,160
COGT icon
6
Cogent Biosciences
COGT
$1.69B
$2.42M 4.22% 3,361,535
CBLK
7
DELISTED
Carbon Black, Inc. Common Stock
CBLK
-181,273 Closed -$4.71M